These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3628474)

  • 1. The urinary 6 beta-hydroxycortisol excretion in man on inducers and inhibitors of the hepatic mixed function oxidase.
    Desager JP; Dumont E; Harvengt C
    Pharmacol Ther; 1987; 33(1):197-9. PubMed ID: 3628474
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary excretion of 6 beta-hydroxycortisol and the time course measurement of enzyme induction in man.
    Ohnhaus EE; Breckenridge AM; Park BK
    Eur J Clin Pharmacol; 1989; 36(1):39-46. PubMed ID: 2917586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme induction by phenobarbitone and vitamin K1 disposition in man.
    Park BK; Wilson AC; Kaatz G; Ohnhaus EE
    Br J Clin Pharmacol; 1984 Jul; 18(1):94-7. PubMed ID: 6743493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity.
    Park BK
    Br J Clin Pharmacol; 1981 Aug; 12(2):97-102. PubMed ID: 7030374
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of phenobarbitone on urinary 6 beta-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithrix jacchus).
    Challiner MR; Park BK; Odum J; Orton TC; Parker GL
    Biochem Pharmacol; 1980 Dec; 29(24):3319-24. PubMed ID: 6971098
    [No Abstract]   [Full Text] [Related]  

  • 6. 6 beta-hydroxycortisol in random urine samples as an indicator of enzyme induction.
    Saenger P
    Clin Pharmacol Ther; 1983 Dec; 34(6):818-21. PubMed ID: 6641098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic mixed function oxidase induction during rifampicin/isoniazid therapy in Indian vegetarians.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):344-8. PubMed ID: 3733284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.
    Ged C; Rouillon JM; Pichard L; Combalbert J; Bressot N; Bories P; Michel H; Beaune P; Maurel P
    Br J Clin Pharmacol; 1989 Oct; 28(4):373-87. PubMed ID: 2590599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.
    Vital Durand D; Hampden C; Boobis AR; Park BK; Davies DS
    Br J Clin Pharmacol; 1986 Jan; 21(1):1-7. PubMed ID: 3947503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [6 beta-hydroxycortisol: a non-invasive reflection of enzymes of drug metabolism].
    Zhiri A; Wellman-Bednawska M; Siest G
    Pathol Biol (Paris); 1987 Sep; 35(7):1087-93. PubMed ID: 3313218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 6-hydroxycortisol excretion in pregnant women: implication of drug-metabolizing enzyme induction.
    Ohkita C; Goto M
    DICP; 1990 Sep; 24(9):814-6. PubMed ID: 2260334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No impairment of antipyrine elimination by the selective anticholinergic drug pirenzepine.
    Paxton JW; Foote SE; Paton DM
    Digestion; 1983; 27(1):44-6. PubMed ID: 6688400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol.
    Staiger C; Schlicht F; Walter E; Gundert-Remy U; Hildebrandt R; de Vries J; Wang NS; Harenberg J; Weber E
    Eur J Clin Pharmacol; 1983; 25(6):797-801. PubMed ID: 6141054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducing effect of feprazone on hepatic drug-metabolizing enzymes in man.
    Morita K; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1986; 31(1):117-8. PubMed ID: 3780819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.
    Moreland TA; Park BK; Rylance GW
    Br J Clin Pharmacol; 1982 Dec; 14(6):861-5. PubMed ID: 6129885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphaphenazole and drug oxidation in man.
    Back DB; Park BK; Tjia JF; Newby SN
    Br J Clin Pharmacol; 1983 Oct; 16(4):460-1. PubMed ID: 6626444
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of velnacrine on the mixed function oxidase system.
    Eccles MJ; Danbury TC; Ford JM; Roberts CJ
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):121-5. PubMed ID: 9248779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endophyte-infected fescue and cimetidine on respiration rates, rectal temperatures and hepatic mixed function oxidase activity as measured by hepatic antipyrine metabolism in sheep.
    Zanzalari KP; Heitmann RN; McLaren JB; Fribourg HA
    J Anim Sci; 1989 Dec; 67(12):3370-8. PubMed ID: 2613583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.
    Larkin JG; McKee PJ; Forrest G; Beastall GH; Park BK; Lowrie JI; Lloyd P; Brodie MJ
    Br J Clin Pharmacol; 1991 Jan; 31(1):65-71. PubMed ID: 2015172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.